IL105569A - Pharmaceutical compositions containing remacemide for the treatment of parkinson's disease - Google Patents
Pharmaceutical compositions containing remacemide for the treatment of parkinson's diseaseInfo
- Publication number
- IL105569A IL105569A IL105569A IL10556993A IL105569A IL 105569 A IL105569 A IL 105569A IL 105569 A IL105569 A IL 105569A IL 10556993 A IL10556993 A IL 10556993A IL 105569 A IL105569 A IL 105569A
- Authority
- IL
- Israel
- Prior art keywords
- remacemide
- parkinson
- disease
- treatment
- pharmaceutical compositions
- Prior art date
Links
- YSGASDXSLKIKOD-UHFFFAOYSA-N 2-amino-N-(1,2-diphenylpropan-2-yl)acetamide Chemical compound C=1C=CC=CC=1C(C)(NC(=O)CN)CC1=CC=CC=C1 YSGASDXSLKIKOD-UHFFFAOYSA-N 0.000 title abstract 3
- 208000018737 Parkinson disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229950000659 remacemide Drugs 0.000 title abstract 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929209599A GB9209599D0 (en) | 1992-05-02 | 1992-05-02 | Novel therapy for the treatment of parkinsons disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL105569A0 IL105569A0 (en) | 1993-08-18 |
| IL105569A true IL105569A (en) | 1997-11-20 |
Family
ID=10714969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL105569A IL105569A (en) | 1992-05-02 | 1993-04-30 | Pharmaceutical compositions containing remacemide for the treatment of parkinson's disease |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0637956B1 (de) |
| JP (1) | JP3542801B2 (de) |
| KR (1) | KR950701216A (de) |
| AT (1) | ATE181669T1 (de) |
| CA (1) | CA2134783C (de) |
| DE (1) | DE69325512T2 (de) |
| DK (1) | DK0637956T3 (de) |
| ES (1) | ES2135476T3 (de) |
| GB (1) | GB9209599D0 (de) |
| GR (1) | GR3031320T3 (de) |
| HU (1) | HU211305A9 (de) |
| IL (1) | IL105569A (de) |
| NZ (2) | NZ299042A (de) |
| SG (1) | SG49202A1 (de) |
| WO (1) | WO1993021910A1 (de) |
| ZA (1) | ZA933086B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025369A (en) * | 1996-05-03 | 2000-02-15 | The Board Of Regents Of The University Nebraska | N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis |
| RU2170576C1 (ru) * | 1999-11-15 | 2001-07-20 | Государственное учреждение науки Институт токсикологии | Гидрохлориды замещенных ацетиленовых аминоспиртов, обладающие антигалоперидоловой активностью |
| IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
| WO2008095221A1 (en) | 2007-02-07 | 2008-08-14 | Gosforth Centre (Holdings) Pty Ltd | Treatment of adhd |
| JP2011529923A (ja) | 2008-08-06 | 2011-12-15 | ゴスフォース センター（ホールディングス）プロプライエタリー リミテッド | 精神障害（ｐｓｙｃｈｉａｔｒｉｃｄｉｓｏｒｄｅｒ）を治療するための組成物および方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU639722B2 (en) * | 1989-10-27 | 1993-08-05 | Astra Aktiebolag | Use of arylalkylamides in the treatment of neurodegenerative diseases |
| DE3940410A1 (de) * | 1989-12-04 | 1991-06-06 | Schering Ag | Neue verwendung von nmda-rezeptor-antagonisten |
-
1992
- 1992-05-02 GB GB929209599A patent/GB9209599D0/en active Pending
-
1993
- 1993-04-30 IL IL105569A patent/IL105569A/xx not_active IP Right Cessation
- 1993-04-30 CA CA002134783A patent/CA2134783C/en not_active Expired - Fee Related
- 1993-04-30 KR KR1019940703908A patent/KR950701216A/ko not_active Ceased
- 1993-04-30 DK DK93911903T patent/DK0637956T3/da active
- 1993-04-30 AT AT93911903T patent/ATE181669T1/de not_active IP Right Cessation
- 1993-04-30 EP EP93911903A patent/EP0637956B1/de not_active Expired - Lifetime
- 1993-04-30 ES ES93911903T patent/ES2135476T3/es not_active Expired - Lifetime
- 1993-04-30 NZ NZ299042A patent/NZ299042A/en not_active IP Right Cessation
- 1993-04-30 ZA ZA933086A patent/ZA933086B/xx unknown
- 1993-04-30 JP JP51908793A patent/JP3542801B2/ja not_active Expired - Fee Related
- 1993-04-30 NZ NZ252728A patent/NZ252728A/en not_active IP Right Cessation
- 1993-04-30 SG SG1996007583A patent/SG49202A1/en unknown
- 1993-04-30 DE DE69325512T patent/DE69325512T2/de not_active Expired - Fee Related
- 1993-04-30 WO PCT/GB1993/000908 patent/WO1993021910A1/en not_active Ceased
-
1995
- 1995-06-23 HU HU95P/P00425P patent/HU211305A9/hu unknown
-
1999
- 1999-09-23 GR GR990402420T patent/GR3031320T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR950701216A (ko) | 1995-03-23 |
| NZ299042A (en) | 2000-07-28 |
| IL105569A0 (en) | 1993-08-18 |
| DE69325512D1 (de) | 1999-08-05 |
| EP0637956A1 (de) | 1995-02-15 |
| GR3031320T3 (en) | 1999-12-31 |
| HU211305A9 (en) | 1995-11-28 |
| CA2134783A1 (en) | 1993-11-11 |
| JP3542801B2 (ja) | 2004-07-14 |
| GB9209599D0 (en) | 1992-06-17 |
| NZ252728A (en) | 1996-11-26 |
| DE69325512T2 (de) | 1999-12-16 |
| ATE181669T1 (de) | 1999-07-15 |
| JPH07506105A (ja) | 1995-07-06 |
| ZA933086B (en) | 1993-11-01 |
| SG49202A1 (en) | 1998-05-18 |
| DK0637956T3 (da) | 1999-11-22 |
| CA2134783C (en) | 2002-08-13 |
| EP0637956B1 (de) | 1999-06-30 |
| ES2135476T3 (es) | 1999-11-01 |
| WO1993021910A1 (en) | 1993-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL108286A0 (en) | Use of anticonvulsants in the treatment of parkinson's disease and parkinsonian syndromes | |
| GB2288732B (en) | Pharmaceutical compositions | |
| HUT75089A (en) | Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent | |
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| ZA892399B (en) | Pharmaceutical compositions of piroxicam in aqueous solution and process for their preparation | |
| IL105569A (en) | Pharmaceutical compositions containing remacemide for the treatment of parkinson's disease | |
| PL318130A1 (en) | Terpenod derivatives (of sarcodictyine)as antineoplastic agents | |
| RU94040865A (ru) | Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью | |
| HUT71838A (en) | Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions | |
| NZ268039A (en) | Use of efaroxan in treating parkinson's disease | |
| SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| IT1262567B (it) | Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia. | |
| TW333453B (en) | Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases | |
| MY110416A (en) | Composition for the treatment of schizophrenia. | |
| IT1275987B1 (it) | Composizione farmaceutica attiva nella cura di affezioni dermatologiche |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |